Chidlow G, Nash M S, De Santis L M, Osborne N N
Nuffield Laboratory of Ophthalmology, University of Oxford, Walton Street, Oxford, OX2 6AW, U.K.
Exp Eye Res. 1999 Dec;69(6):587-93. doi: 10.1006/exer.1999.0756.
The aims of this study were first to investigate the effect of topical instillation of the 5-HT(1A)receptor agonist 8-OH-DPAT on intraocular pressure (IOP) in normotensive rabbits and second to establish whether the drug reaches the aqueous humour of treated and contralateral eyes at concentrations sufficient to activate ciliary epithelial 5-HT(1A)receptors. Following topical unilateral instillation of (+/-), (+) or (-)8-OH-DPAT, the IOP of rabbits was measured using an applanation tonometer. For the penetration study, [(3)H]8-OH-DPAT was instilled into one eye of each rabbit. Animals were killed after 30 min and the radioactive content of treated and contralateral ocular tissues was assessed. Administration of (+/-)8-OH-DPAT caused dose-dependent decreases in IOP in treated eyes of rabbits during the light and dark. The full 5-HT(1A)agonist (+)8-OH-DPAT was shown to be a more effective hypotensive agent than the partial agonist (-)8-OH-DPAT. The effect of (+/-)8-OH-DPAT on IOP was blocked by pretreatment with pindolol, a mixed 5-HT(1A)antagonist/beta-blocker, but not by the specific beta-blocker betaxolol. After instillation of [(3)H]8-OH-DPAT, peak levels of radioactivity were found in the cornea, followed by similar amounts in the iris-ciliary body and aqueous. There was negligible radioactivity present in tissues of the contralateral eye. This study demonstrates that topical administration of the 5-HT(1A)agonist 8-OH-DPAT dose-dependently decreases IOP in normotensive rabbits during the light and dark. The action of 8-OH-DPAT is presumably local to the anterior uvea as IOP was reduced only in treated eyes and [(3)H]8-OH-DPAT failed to reach the contralateral eye after unilateral instillation. Moreover, since 5-HT(1A)receptors are located in the rabbit ciliary epithelium and the effect of 8-OH-DPAT is blocked by a recognized 5-HT(1A)antagonist, the mechanisms of action of 8-OH-DPAT may well involve a decreased secretion of aqueous humour.
本研究的目的,其一,是研究向血压正常的家兔眼局部滴注5-羟色胺(5-HT)(1A)受体激动剂8-羟基二丙胺四乙酸(8-OH-DPAT)对眼压(IOP)的影响;其二,是确定该药物是否能以足以激活睫状上皮5-HT(1A)受体的浓度到达用药眼和对侧眼的房水。在家兔单眼局部滴注(±)、(+)或(-)8-OH-DPAT后,使用压平眼压计测量家兔的眼压。在渗透研究中,将[³H]8-OH-DPAT滴入每只家兔的一只眼睛。30分钟后处死动物,并评估用药眼和对侧眼组织的放射性含量。滴注(±)8-OH-DPAT会使家兔用药眼在明、暗条件下的眼压出现剂量依赖性降低。已证明,完全5-HT(1A)激动剂(+)8-OH-DPAT作为降压药比部分激动剂(-)8-OH-DPAT更有效。(±)8-OH-DPAT对眼压的作用可被混合5-HT(1A)拮抗剂/β受体阻滞剂吲哚洛尔预处理所阻断,但不能被特异性β受体阻滞剂倍他洛尔阻断。滴注[³H]8-OH-DPAT后,在角膜中发现放射性的峰值水平,其次是在虹膜睫状体和房水中的放射性水平相似。对侧眼组织中的放射性可忽略不计。本研究表明,向血压正常的家兔眼局部滴注5-HT(1A)激动剂8-OH-DPAT,在明、暗条件下均能使眼压出现剂量依赖性降低。8-OH-DPAT的作用可能局限于眼前葡萄膜,因为仅用药眼的眼压降低,且单侧滴注[³H]8-OH-DPAT后未能到达对侧眼。此外,由于5-HT(1A)受体位于家兔睫状上皮,且8-OH-DPAT的作用可被公认的5-HT(1A)拮抗剂阻断,8-OH-DPAT的作用机制很可能涉及房水分泌减少。